This content is machine translated AHA Scientific Sessions 2018 Dapagliflozin reduces heart failure hospitalization rate Diabetes is associated with an increased cardiovascular risk, which should be taken into account therapeutically. In 2015, the EMPA-REG OUTCOME study demonstrated positive cardiovascular effects of the SGLT-2 inhibitor empagliflozin.…
View Post 9 min This content is machine translated vvECMO and vaECLS Bridge-to-decision in respiratory failure and cardiogenic shock. Studies such as CESAR or SHOCK II, but also the further development of pumps, oxygenators and perfusion tubing have contributed to the fact that therapy with ECMO and ECLS has…
View Post 7 min This content is machine translated Peripheral arterial occlusive disease Rare causes and differential diagnoses The clinic of degenerative changes is difficult to distinguish from that of peripheral arterial disease (PAVD), and measurement of ABI is indicative.
View Post 7 min This content is machine translated Marfan syndrome and related connective tissue diseases How is long-term cardiovascular care provided to patients? Surgical treatment of patients with hereditary connective tissue disease aims to prevent aortic dissection. This is because it is responsible for the high mortality rate of the patient population. When…
View Post 8 min This content is machine translated Operation in focus When and how is surgical therapy for PAVK performed? The surgical techniques used to rehabilitate peripheral arterial disease (PAVD) are thromboendarterectomy and bypass grafting. Which procedure is used when, how does the operation proceed and what should be taken…
View Post 7 min This content is machine translated Chronic heart failure MitraClips: What do studies say? The use of percutaneous mitral valve repair using a MitraClip device for the treatment of (moderately) severe functional mitral regurgitation is controversial. Previous studies were either terminated due to insufficient…
View Post 10 min This content is machine translated Cardio-Oncology Challenges of new cancer therapies Innovative therapies have improved the prognosis of many oncological diseases. A major limitation for the individual prognosis are disease- and therapy-associated cardiovascular complications. Even rare events can have serious consequences.
View Post 10 min This content is machine translated ESC in Munich Studies bring clarity to two controversial issues After an unsuccessful trial several years ago, the Germans are now using TIM-HF2 to show for the first time a survival benefit from telemonitoring in heart failure. And: Safe weight…
View Post 7 min This content is machine translated Psychological dimension of a myocardial infarction The heart attack as psychotrauma Psychological disorders such as depression or ACS-induced PTSD may occur after myocardial infarction. Therefore, psychological support for heart attack patients is central. This is because the psyche influences both the…
View Post 7 min This content is machine translated Gender Medicine Coronary heart disease in women Until menopause, female hormones reduce cardiovascular risk. But the lack of awareness among women that they too can develop CHD is dangerous.
View Post 4 min This content is machine translated Iron Academy, Zurich Transfusions and iron overload Free iron is toxic and iron overload can lead to fatal organ damage: An Overview of Interactions and Dangers of Iron Overload in Chronic Transfusion and Ineffective Erythropoiesis.
